Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Association between periodontal disease and mortality in people with CKD: a meta-analysis of cohort studies

BMC NephrologyBMC series – open, inclusive and trusted201718:269

https://doi.org/10.1186/s12882-017-0680-9

Received: 25 February 2017

Accepted: 28 July 2017

Published: 16 August 2017

Abstracts

Background

Periodontal disease occurs relatively prevalently in people with chronic kidney disease (CKD), but it remains indeterminate whether periodontal disease is an independent risk factor for premature death in this population. Interventions to reduce mortality in CKD population consistently yield to unsatisfactory results and new targets are necessitated. So this meta-analysis aimed to evaluate the association between periodontal disease and mortality in the CKD population.

Methods

Pubmed, Embase, Web of Science, Scopus and abstracts from recent relevant meeting were searched by two authors independently. Relative risks (RRs) with 95% confidence intervals (CIs) were calculated for overall and subgroup meta-analyses. Statistical heterogeneity was explored by chi-square test and quantified by the I2 statistic.

Results

Eight cohort studies comprising 5477 individuals with CKD were incorporated. The overall pooled data demonstrated that periodontal disease was associated with all-cause death in CKD population (RR, 1.254; 95% CI 1.046–1.503; P = 0.005), with a moderate heterogeneity, I2 = 52.2%. However, no evident association was observed between periodontal disease and cardiovascular mortality (RR, 1.30, 95% CI, 0.82–2.06; P = 0.259). Besides, statistical heterogeneity was substantial (I2 = 72.5%; P = 0.012). Associations for mortality were similar between subgroups, such as the different stages of CKD, adjustment for confounding factors. Specific to all-cause death, sensitivity and cumulative analyses both suggested that our results were robust. As for cardiovascular mortality, the association with periodontal disease needs to be further strengthened.

Conclusions

We demonstrated that periodontal disease was associated with an increased risk of all-cause death in CKD people. Yet no adequate evidence suggested periodontal disease was also at elevated risk for cardiovascular death.

Keywords

Cohort studies, meta-analysis Mortality Periodontal disease Outcomes

Background

In the past decade, chronic kidney disease (CKD) has received mounting attention as a leading public health problem worldwide [1]. It is well established that people with CKD are more susceptible to cardiovascular morbidity and mortality compared to the general population, especially for individuals have advanced CKD requiring renal replacement therapy [24]. It estimates that approximately 10–20 of every 100 people treated with dialysis die each year [5]. Cardiovascular diseases are thought to be the main cause of death, accounting for 40% of all-cause mortality for this population [6]. However, traditional risk factors are inadequate to decipher the heightened death risk and the high prevalence of cardiovascular disease. Consequently, nontraditional risk factors have also been widely investigated to explain this phenomenon. Among them, chronic inflammation, defined as persistently high levels of inflammatory biomarkers, is highly prevalent and may contribute to cardiovascular diseases in hemodialysis patients [7].

Periodontal disease is a common group of inflammatory diseases caused by interaction between gram-negative periodontal bacterial species and components of the host immune response [8]. Reportedly, about half of adult people around the world suffer from severe periodontitis, which will finally lead to tooth loss [9]. Besides, previous studies suggested that poor periodontal health is more prevalent and severe in adults with CKD [10]. Although links of periodontal disease with elevated all-cause and cardiovascular mortality were extensively ascertained in the general population [11, 12], the effects of periodontal disease on mortality in CKD people have not been definitively demonstrated.

Up to now, individual study with respect to the relationship between periodontal disease and premature death in people with CKD was not convincing enough, which merely offered imprecise and inconsistent risk estimates [1315]. In 2009, Kshirsagar et al. performed a retrospective study based on 168 adult hemodialysis patients, and firstly found that moderate-severe periodontal disease was significantly associated with increased risk of cardiovascular death, even after adjustment of age, gender, center and dialysis vintage, smoking status and history of diabetes mellitus or hypertension [14]. While the association with all-cause death was not noted. However, another prospective observational study by Ricardo et al. recently reported a thoroughly opposite result that periodontal disease was associated with all-cause mortality, but not cardiovascular death among individuals with CKD [13]. Besides, randomized trials of interventions for periodontal disease in CKD populations are quite scarce and limited by sample size, duration and the use of surrogate indicators [16, 17].

Allowing for its potential but uncertain prognostic effects of periodontal disease in CKD and the need to adopt additional intervention, we therefore conducted a systematic review and meta-analysis to make clear the relevance between periodontal disease and mortality in people with CKD. The effects of diagnostic methods for periodontal disease and the severity of CKD were carefully considered in the present study.

Methods

This systematic review and meta-analysis is conducted in accordance with the Meta-analysis of Observational Studies in Epidemiology (MOOSE) guidelines [18] and was registered at International Prospective Register of Systematic Reviews (number CRD42016049838).

Search strategy and selection criteria

Relevant studies were identified by searching the following data sources between 1950 and 1 October 2016: Pubmed, Embase, Scopus, Web of science and abstracts from the 2004–2015 European Renal Association European Dialysis and Transplant Association (ERA-EDTA) Congress. We used Medical Subject Headings (MeSH) and text words of chronic kidney disease, renal replacement therapy, dialysis, kidney transplantation, periodontal diseases and mortality by formulating optimally sensitive search strategies, see Supplementary Search Strategy. Additionally, manual review of reference lists of all included articles was also performed. All potentially eligible studies were retrieved and examined without the limit of languages. If the same cases were reported in more than one study, only the study with the most complete data was included.

Eligibility criteria

Inclusion criteria: (1) cohort studies that reported the relationship between periodontal diseases and the risk of mortality within adult CKD population, (2) studies in which death risks were evaluated according to periodontal status at baseline, (3) studies in which periodontal status was examined by professional dentists and (4) studies that contained the minimum information necessary to estimate the risk estimates (hazard ratios [HRs], relative risks [RRs]) with 95% confidence interval (CI). Exclusion criteria: (1) cross-sectional studies, (2) studies without estimates of the HRs or RRs of death related to periodontal disease. In addition, no clinical interventions were compared within the included studies.

Diagnostic criteria of periodontal disease

Measurements for diagnose of periodontal disease mainly included pocket probing depth (PPD), clinical attachments levels (CALs), bleeding on probing, and the alveolar bone status evaluated by radiographic scans. The periodontal clinical examination involving both PPD and CALs measurements was selected as the gold standard, according to the guidelines of the American Academy of Periodontology [19]. Besides, The World Health Organization (WHO) Community Periodontal Index of Treatment Needs (CPITN) is also a validated epidemiological screening tool of periodontal disease [20].

Diagnostic criteria of CKD

CKD was defined according to the KDOQI guideline [21] (structural or urinary abnormalities with or without glomerular filtration rate < 60 ml/min/1.73m2), including people undergoing dialysis and kidney transplantation.

Data extraction and quality assessment

Two investigators independently screened the titles and abstracts from all eligible studies for relevance (ZJ and JH). Discrepancies between investigators were solved by a third reviewer (SM) until a consensus was reached. In addition, authors were contacted to identify the missing data and make sure issues of interest. Extracted data included the surname of first author, year of publication, study name, study location, stage of kidney disease (non-dialysis-dependent CKD, receiving dialysis, or transplant recipient), study design, sample size, age and gender of participants, duration of follow-up, baseline prevalence of periodontal disease, diagnostic criteria of periodontal disease and CKD, adjusted covariates in multivariable analyses. Adjusted risk estimates (HRs or RRs) were extracted for the following mergence and further analysis. We selected results from the full statistical model that adjusted for the largest number of potential confounders.

The Newcastle-Ottawa scale was used to evaluate the quality of individual studies [22]. In brief, a maximum of 9 points was assigned to each study: 4 for selection, 2 for comparability, and 3 for outcomes. A final score > 6 was regarded as high quality (low risk of bias). Two authors (ZJ and JH) independently extracted the data and gave each study a score. Differences were solved by discussion to achieve consensus, and finally confirmed by another author (SM).

Outcome measures

We defined the main outcome of interest as all-cause mortality. The secondary outcome was cardiovascular mortality. We extracted risk estimates and 95% CIs (confidence intervals) for outcomes with CKD patients who had no or mild periodontal diseases as the referent category.

Statistical analysis

All analyses were conducted by using DerSimonian-Laird random-effects and inverse variance model. Multivariable-adjusted risk estimates of dichotomous data were pooled and RRs were presented.

Chi-square test and I2 inspection were carried out to determine the heterogeneity between included studies. I2 > 50% or Q test P ≤ 0.1 were considered to be substantial heterogeneity.

Subgroup analysis was conducted to assess the effect of CKD stage (CKD stage 3–5, CKD 5D, and transplantation), adjustment for confounding variables, study design, study duration, regions, diagnostic criteria of periodontal disease, and reference population.

We performed sensitivity analyses by omitting individual studies stepwise and exploring the effect of individual studies on the overall estimates. Publication bias was evaluated by visual inspection of funnel plot symmetry and Egger’s regression test. All tests were 2-sided and P value <0.05 was considered statistically significant. All analyses were performed using STATA version 13.0 software (STATA Corp, College Station, Texas, USA).

Results

We initially retrieved a total of 7772 titles and abstracts. Full-text articles of 24 were obtained for further assessment. We finally identified eight cohort studies in our meta-analysis, including seven prospective cohort studies [13, 15, 2327], and one retrospective cohort study [14]. Of them, the study by Palmer was reported as a ERA-EDTA conference abstract [23]. Reasons for exclusion of sixteen studies were overlapped data (n = 3) [2830], studies were lack of data (n = 5) [3135], commentary study (n = 1) [36], inappropriate study design (cross-sectional study, n = 4 [3740]; intervention study, n = 1 [41]), inappropriate exposure (tooth loss) n = 2 [42, 43]. Figure 1 illustrates our study selection process.
Fig. 1

Flow diagram summarizing study identification and selection

Four studies used periodontal-disease-free participants as reference group [13, 2527], three studies enrolled patients with no to mild periodontal disease as reference group [14, 15, 23], and one study used participants with no or moderate periodontal disease as reference group [24]. Only the study by Blach did not adjust for covariant variables [24]. Countries of origin included Europe, United States of America and China. Three studies were populations with CKD stages 3–5 [13, 26, 27], four studies were patients undergoing hemodialysis [14, 15, 23, 25], and one study was of kidney transplant recipients [24]. All of included studies reported diagnostic criteria and methods for periodontal disease. Among them, PPD and CALs were used in five studies [1315, 25, 26], and CPITN criterion was used in the remained three studies [23, 24, 27]. Data for the risks of mortality were evaluated according to periodontal status at baseline. Characteristics of included studies were summarized in Table 1, with adjusted covariates of each study given in Additional file 1: Table S1. It had been confirmed that no cross-over exists between our included studies.
Table 1

Characteristics of included studies

Study

Design

Region

Age (years)

No. of participants (no. of male participants)

Median follow-up duration (years)

CKD stage

Assessment methods and definitions for periodontal disease

Outcome assessment

Blach (26) 2009

Prospective cohort study

Poland

Mean 42.5 years

117 (77)

60 months

Kidney transplantation

CPITN

All cause death

Kshirsagar (15) 2009

Retrospective study

America

Mean 53.6 years

168 (77)

18 months

hemodialysis

PPD, CAL

All cause and cardiovascular death

Chen (16) 2011

Prospective cohort study

Taiwan

58.8 ± 0.8 years

253 (117)

6 years

Hemodialysis

PPD, CAL

All cause and cardiovascular death

Souza (24) 2014

Prospective cohort study

Brazil

Mean 50 years

122 (79)

64.1 ± 11.2 months

Clinically stable patients undergoing HD

PPD, CAL

All cause death

Palmer (28) 2015

Prospective cohort study

Europe and South America

Mean 59.1 years

3338 (1973)

6150 person-years of follow-up

Hemodialysis

CPITN

All cause and cardiovascular death

Ricardo (14) 2015

Prospective cohort study

America

Mean 53.5 years

1335 (544)

14 years

CKD

PPD, CAL

All cause and cardiovascular death

Chen (27) 2015

Longitudinal, observational, community-based cohort study

Taiwan

≥65 years

NA

3.8 years

CKD without ESRD

CPITN

All-cause death

Ruokonen (25) 2016

Prospective cohort study

Finland

 

144 (97)

157 months

Predialysis

PPD,CAL

All cause death

Abbreviations: PPD periodontal probing depth, CAL clinical attachment loss, PDI periodontal disease index, CPITN Community Periodontal Index of Treatment Needs, BMI body mass index, CVD chronic vascular disease, CRP high sensitivity C-reaction protein, eGFR estimated glomerular filtration rate, DMF-T decayed, missing, and filled teeth index, NA not available

Risk of bias in the included studies were summarized in Table 2. We judged 5 [1315, 25, 26] and 3 [23, 24, 27] of 8 studies to be low or moderate risk of bias overall. The common limitations in the included studies were that age and other important confounders had not been matched between exposure groups and control groups. Besides, follow-up is not long enough for outcomes to occur in some studies.
Table 2

Assessment of study quality

Study year

Quality indicators from the Newcastle-Ottawa scale

Score

Selection

Comparable

Outcome assessment

1

2

3

4

5

6

7

8

9

Blach (26) 2009

*

*

*

*

   

*

*

6

Kshirsagar (15) 2009

*

*

*

*

*

*

*

 

*

8

Chen (16) 2011

*

*

*

*

 

*

*

*

*

8

Souza (24) 2014

*

*

*

*

 

*

*

*

*

8

Palmer (28) 2015

*

*

*

*

  

*

  

5

Ricardo (14) 2015

*

*

*

*

  

*

*

*

7

Chen (27) 2015

 

*

*

*

 

*

*

 

*

6

Ruokonen (25) 2016

*

*

*

*

 

*

*

*

*

8

Footnote: For cohort studies, 1 indicates exposed cohort truly representative; 2, non-exposed cohort drawn from the same community; 3, ascertainment of exposure; 4, outcome of interest not present at start; 5, cohorts comparable on basis of age; 6, cohorts comparable on other factor(s); 7, quality of outcome assessment; 8, follow-up long enough for outcomes to occur; and 9, complete accounting for cohorts. Each asterisk represents one star in the Newcastle-Ottawa scale system. The maximum number of stars is 2 for comparability and 1 for each of the other categories, for a total of up to 10 stars

Periodontal disease and all-cause death in CKD people

A total of eight cohort studies were included in the analysis of all-cause death, comprising 5477 participants and 1492 cases of all-cause death (data from Chen 2015 [27] were not specified). The incidence rate of all-cause death ranged from 3.41% to 46.07%. Overall, there existed a certain correlation between periodontal disease and risk of all-cause mortality in people with CKD (RR, 1.254; 95% CI 1.046–1.503; Fig. 2). Moderate heterogeneity was observed (I2 = 52.2%, P = 0.041). Therefore, subgroup analyses were conducted to explore sources of heterogeneity. As shown in Table 3, we found that results were similar across different stages of CKD (CKD with renal replacement therapy vs earlier stages of CKD), adjustment for confounding factors, regions, and reference population (healthy population vs healthy to mild periodontal disease population), with P values for subgroup difference were 0.79, 0.77, 0.99 and 0.66, respectively. In addition, the extent of adjustment in multivariable analyses did not statistically influence the relationship between periodontal disease and all-cause death as well. However, estimate was slightly modified by the study duration (less than five years vs longer than five years) and diagnostic criteria for periodontal disease. After limiting to individuals with follow-up duration less than five years, increased risk of all-cause death was not observed, with RR = 1.116, 95% CI 0.855–1.457. Due to insufficient data, we were unable to further compare the modality of renal replacement therapy on the association between periodontal disease and all-cause death in CKD population.
Fig. 2

Forest plot of association of periodontal disease and risk of all-cause death in CKD population

Table 3

Subgroup analyses for the effects of periodontal disease on all-cause mortality in people with CKD

Overall and subgroup analysis

No. of studies

Heterogeneity

Model

Meta-analysis

P value between subgroups

P

I2 (%)

RR

95% CI

P

 

Overall

8

0.041

52.2

Random-effect

1.254

1.046–1.503

0.015

 

CKD stage

       

0.79

CKD stage 3–5

3

0.75

0.0%

Fix-effect

1.245

1.119–1.385

0.000

 

CKD stage 5D (hemodialysis)

4

0.030

66.4%

Random-effect

1.315

0.885–1.954

0.176

 

Transplant

1

NA

NA

NA

7.17

1.4–76.4

NA

 

Adjustment for confounding factors

        

Unadjusted

1

NA

NA

NA

7.17

1.4–76.4

NA

 

Adjusted

7

0.072

48.2%

Fixed-effect

1.194

1.091–1.306

0.016

0.77

Adjusted for smoking and other variables

6

0.058

53.3%

Random-effect

1.209

1.016–1.438

0.032

 

Adjusted for diabetes and other variables

6

0.093

47.1%

Fixed-effect

1.175

1.071–1.288

0.001

 

Adjusted for diabetes, hypertension and other variables

4

0.664

0.0%

Fixed-effect

1.264

1.137–1.404

0.000

 

Study duration

       

0.14

Short (< 5 years)

3

0.029

71.9%

Random-effect

1.116

0.855–1.457

0.418

 

Long (≥ 5 years)

5

0.448

0.0%

Fixed-effect

1.429

1.173–1.742

0.000

 

Diagnostic criteria for periodontal disease

       

0.23

PPD, CALs

5

0.838

0%

Fixed-effect

1.422

1.171–1.727

0.000

 

CPITN

3

0.009

78.8%

Random-effect

1.125

0.812–1.559

0.478

 

Regions

       

0.99

Asian countries

2

0.227

31.6%

Fixed-effect

1.257

1.123–1.407

0.000

 

European countries and USA

6

0.045

55.8%

Random-effect

1.259

0.927–1.710

0.14

 

Reference population

       

0.66

Healthy

4

0.752

0.0%

Fixed-effect

1.253

1.128–1.393

0.000

 

Healthy to mild periodontal disease

4

0.012

72.4%

Random-effect

1.410

0.844–2.356

0.189

 

Abbreviations: RR relative risk, CI confidence interval, PPD pocket probing depth, CALs clinical attachment levels, CPITN Community Periodontal Index of Treatment Needs Index, NA data not available

Sensitivity analyses were conducted by excluding individual studies stepwise. Results revealed that relative risks of all-cause death were not remarkably changed, thereby indicating that our results were hardly influenced by small-study effects. The pooled RR was 1.194 (95% CI = 1.091–1.306, P = 0.000) when the study did not adjust for any confounders was omitted [24]. While the study by Palmer which was published as a conference abstract was further excluded, the association between periodontal disease and all-cause death in CKD people became stronger, with RR = 1.279, 95% CI, 1.156–1.415, P = 0.000. Interestingly, heterogeneity disappeared in the remained studies, with I2 = 0.0%, P = 0.700. Then we performed a cumulative analysis based on the remained studies in chronological order. Results demonstrated a stable, significant positive association between periodontal disease and all-cause death in people with CKD, shown in Additional file 2: Figure S1. In addition, when we restricted studies to those with low risks of bias, the pooled RR was 1.422, 95% CI, 1.171–1.727, P = 0.000, as depicted in Additional file 3: Figure S2.

Periodontal disease and cardiovascular death in CKD people

Of included eight studies, four studies reported the relevance between periodontal disease and cardiovascular mortality [1315, 23]. Based on a median follow-up of 5.8 years, cardiovascular mortality incidence rates ranged from 8.3% to 23.6%, and the total incidence rate was 13.86%. Random-effects model was utilized to pool corresponding data of individual studies. Results revealed that periodontal disease was not statistically related to the risk of cardiovascular mortality in patients with CKD (RR = 1.30, 95% CI, 0.82–2.06; P = 0.259; presented in Fig. 3), with a high heterogeneity (I2 = 72.5%; P = 0.012).
Fig. 3

Forest plot of association of periodontal disease and risk of cardiovascular death in CKD population

Subgroup analysis was also performed according to study design, duration of follow-up and reference population. Results indicated that the association between periodontal disease and the risk of cardiovascular death was consistent among subgroups, with P values for subgroup difference were 0.23, 0.78, 0.94, respectively.

Eliminating one study at a time, except the study by Palmer [23], all yielded similar effect sizes in magnitude and direction to the overall estimates. But after omitting the study with moderate risk of bias [23], periodontal disease was at a distinctly increased risk for cardiovascular death in CKD people, with pooled RR of 1.469, 95% CI, 1.094–1.972, P = 0.011. Moreover, only mild heterogeneity was found in the remained studies, I2 = 37.3%, P = 0.203.

Publication bias

Evidence for publication bias was not noticeable for all-cause death risk on the basis of visual inspection of the funnel plot (Fig. 4) and the Egger’s regression test, with P = 0.228. Funnel plot was not conducted for the risk of cardiovascular mortality because of too few included studies, with P value for Egger’s regression test was 0.116.
Fig. 4

Funnel plot of relative risk of all-cause death in CKD people with periodontal disease

Discussion

As far as our review team is aware, this study is the first meta-analysis comprehensively evaluating the association of periodontal disease with all-cause and cardiovascular mortality in people who have CKD. A previous systematic review of observational studies by Ruospo et al. have investigated the prevalence and severity of oral disease in adults with CKD, which told us that oral disease is common in CKD people, presented with high incidence of periodontitis, edentulism, mucosal disease, salivary abnormalities and bad oral hygiene [44]. However, the association of periodontal disease with mortality was not meta-analyzed due to the shortage of three independent populations. In our study, the final results manifest that periodontal disease is related with an elevated risk of premature death in CKD population.

Given that smoking is a shared risk factor for periodontal disease and mortality [45, 46], we performed a subgroup analysis by restricting to studies in which smoking status was adjusted, which generated a similar risk of all-cause death. Besides smoking, other confounders such as diabetes mellitus, hypertension and CRP were further analyzed. All kinds of analyses for adjusted estimates suggested a significant relevance between periodontal disease and all-cause mortality. In addition, the association between periodontal disease and death is similar across different races and reference populations. As a whole, these results indicated that periodontal disease could be an independent risk factor of all-cause death in CKD people.

Inconsistency was observed while data were pooled from few studies with follow-up duration less than 5 years. This phenomenon might remind us of the existence of a time lag, with regard to the long-term effect of periodontal disease on the risk of all-cause death in people with CKD.

It is puzzling that meta-analysis of data from large prospective cohort studies showed that CKD people with periodontal disease were not at an increased risk of all-cause death, with RR = 1.146, 95% CI 0.929–1.414. The study by Palmer is one of the three largest cohorts. Adequate evidence revealed that this study, which was based on the ORAL-D cohort study, is the biggest source of heterogeneity among eight included studies. Strangely enough, full-text articles of corresponding data have not yet been published in authority journal, instead, only some related conference abstracts are found [23, 28]. Therefore, it is inferred that the reason for such unstable results pooled from large cohorts lies in the existence of the study by Palmer [23]. Further analysis is limited because we are unable to get more detail information.

Associations between CKD and periodontal disease have been documented in numerous studies [4749]. Bidirectional relationship between them was confirmed by using a structural modeling methodology, allow for simultaneous modeling of direct and indirect effects [50]. Nevertheless, the exact mechanisms account for the existence of their associations in CKD people are still unknown. Periodontal disease may have a direct causal role in the mortality risks for CKD people. Plenty of evidence manifested that periodontal disease is linked with an increase of several markers of chronic inflammation [33, 51, 52], such as C-reactive protein (CRP), interleukin-6 and fibrinogen. Bacteria involved in periodontal disease can get into the systemic circulation, invade the endothelium of major arteries, then further exacerbate systemic inflammation [53], particularly for hemodialysis individuals, who maintain in chronic persistent inflammation status, per se. As reported that periodontal disease can lead to adverse outcomes in CKD individuals via endothelial dysfunction and vascular injury [54]. A small randomized controlled trial revealed that treatment of periodontitis in dialysis patients improved clinical outcomes of periodontitis severity, but did not generate an obvious impact on serum markers of inflammation [55]. In our present analysis, pooled data from two studies which adjusted CRP levels confirmed the association between periodontal disease and all-cause death in CKD individuals as well.

Another explanation for the increased mortality may be related to poor nutritional status, such as lower albumin and elevated blood urea nitrogen (BUN), Cr levels. Malnutrition is extensively found in CKD population, which impairs the immune defense of the hosts and markedly changes the oral microbial ecology [56, 57]. Through systematic unhealthy nutritional status, CKD can interact with periodontal disease, then contribute to diseases progress together. Previous studies revealed that there existed a significant association between malnutrition and severity of periodontitis [51, 58, 59]. As a consequence, nutrition abnormality can intensify the severity of periodontal disease, which may ultimately develop into life-threatening disease.

Except the potential existence of direct pathways explaining the link between periodontal disease and bad clinical outcomes, it is also plausible that they share similar risk factors in CKD population, such as smoking status, diabetes and hypertension. Corresponding adjusted results were mentioned above, which manifested that other pathogenic mechanisms, other than common risk factor, may take a bigger part in this process.

Different from all-cause death, the definite relevance between periodontal disease and cardiovascular mortality in CKD people is not observed in the present meta-analysis, which excludes the mechanism that elevated all-cause mortality is mediated by cardiovascular disease progression. A large number of publications have suggested that periodontal disease correlated significantly with death from various kinds of cancer [60, 61], diabetes [62], and respiratory disease [63, 64]. In addition, the study by Ruokonen also revealed that noncardiovascular systemic diseases, such as infection, and malignant disease were the main causes of death among CKD populations, which show significant association with periodontal disease [26]. Therefore, these noncardiovascular factors may be suitable to explain the increased risk of all-cause death. Nevertheless, we have to admit that the effects of periodontal disease on the cardiovascular death are less certain, because studies exploring the links between periodontal disease and cardiovascular mortality in CKD are still too few. Larger prospective studies will be useful for better understanding of their association. Hence, we suggest some caution in the interpretation of this result.

Strengths and limitation

To the best of our knowledge, this meta-analysis is the first of its kind to investigate the controversial issues of whether periodontal disease is associated with all-cause and cardiovascular mortality in CKD population. As some detail data were obtained by contacting with authors, this meta-analysis incorporated some extra unpublished data. In addition, we only included population-based cohort studies, which provide the highest level of evidence in the observational studies.

Limitations of this meta-analysis should be acknowledged, too. Firstly, because of the limited number of original studies and the inevitable methodological limitations of observational studies, our results should be prudently considered as relevant inference and hypothesis-exploring. Just as other results from observational studies, associations do not imply causality certainly.

Secondly, Some studies failed to report the severity of periodontal disease [25, 27], and thus data were unable to allow for the conduct of dose-response analyses.

Thirdly, unadjusted estimate from the study of Blach was also pooled in our meta-analysis.

Fourthly, statistical heterogeneity could not be fully explained after subgroup analyses. We were unable to further investigate the heterogeneity of gender, modalities of renal replacement therapy, method of measuring periodontal disease from other sources, due to the rather small number of included studies.

Fifthly, periodontal disease represents a potentially modifiable risk factor for individuals with CKD. However, longitudinal changes in periodontal conditions during follow up period was not illustrated in almost all studies and it might partially affect the estimates.

Finally, limited information available on periodontal disease and cardiovascular death is also a drawback to our study. Thus this result should still be treated with caution.

Conclusions

Overall, our findings demonstrated that periodontal disease is significantly associated with an increased risk of all-cause death in people have CKD. However, no adequate evidence proves that periodontal disease is also of an elevated risk for cardiovascular death so far. This meta-analysis of cohort studies incorporated the latest available proof and provided up-to-date insights into the relationship of periodontal disease and mortality risks in CKD people. More high-quality and large scale epidemiological cohorts are required to further establish and verify this association. Additionally, animal studies are also necessary to explore the underlying mechanisms.

Abbreviations

95% CI: 

95% Confidential intervals

BUN: 

Blood urea nitrogen

CALs: 

Clinical attachment levels

CKD: 

Chronic kidney disease

CPITN: 

Community Periodontal Index of Treatment Needs

CRP: 

C-reactive protein

HRs: 

Hazard risks

PPD: 

Pocket probing depth

RRs: 

Relative risks

WHO: 

World health organization

Declarations

Acknowledgments

We thank all of the investigators who responded our inquiries regarding their original studies.

Funding

This work was supported by the National Fund Committee of China (2012CB517603, 2012AA02A512).

Availability of data and materials

All the data supporting the conclusions of this article are contained within the manuscript. The individual patient-level dataset was not made publically available due to containing potentially identifying patient data; however, the study dataset may be made available from the authors upon request.

Authors’ contributions

CJH and SM contributed to conception and design of the study. ZJ and JH contributed to the data acquisition, analysis and interpretation of the data. ZJ and JH contributed to writing and editing the manuscript. All authors commented on drafts of the paper and have approved the final draft of the manuscript.

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interest

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Kidney Disease Center, The First Affiliated Hospital, College of Medicine, Zhejiang University
(2)
Kidney Disease Immunology Laboratory, The Third Grade Laboratory, State Administration of Traditional Chinese Medicine of PR China
(3)
Key Laboratory of Multiple Organ Transplantation, Ministry of Health, Key Laboratory of Nephropathy
(4)
Department of General Surgery, Taihe Hospital, Hubei University of Medicine

References

  1. Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, Jafar TH, Heerspink HJ, Mann JF, Matsushita K, Wen CP. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet (London, England). 2013;382(9889):339–52.View ArticleGoogle Scholar
  2. Mahmoodi BK, Matsushita K, Woodward M, Blankestijn PJ, Cirillo M, Ohkubo T, Rossing P, Sarnak MJ, Stengel B, Yamagishi K, et al. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis. Lancet (London, England). 2012;380(9854):1649–61.View ArticleGoogle Scholar
  3. Singh NP, Ingle GK, Saini VK, Jami A, Beniwal P, Lal M, Meena GS. Prevalence of low glomerular filtration rate, proteinuria and associated risk factors in North India using Cockcroft-Gault and modification of diet in renal disease equation: an observational, cross-sectional study. BMC Nephrol. 2009;10:4.View ArticlePubMedPubMed CentralGoogle Scholar
  4. Chen J, Wildman RP, Gu D, Kusek JW, Spruill M, Reynolds K, Liu D, Hamm LL, Whelton PK, He J. Prevalence of decreased kidney function in Chinese adults aged 35 to 74 years. Kidney Int. 2005;68(6):2837–45.View ArticlePubMedGoogle Scholar
  5. Smith DH, Gullion CM, Nichols G, Keith DS, Brown JB. Cost of medical care for chronic kidney disease and comorbidity among enrollees in a large HMO population. J Am Soc Nephrol. 2004;15(5):1300–6.View ArticlePubMedGoogle Scholar
  6. Pecoits-Filho R, Lindholm B, Stenvinkel P. The malnutrition, inflammation, and atherosclerosis (MIA) syndrome -- the heart of the matter. Nephrol Dial Transplant. 2002;17(Suppl 11):28–31.View ArticlePubMedGoogle Scholar
  7. Meuwese CL, Stenvinkel P, Dekker FW, Carrero JJ. Monitoring of inflammation in patients on dialysis: forewarned is forearmed. Nat Rev Nephrol. 2011;7(3):166–76.View ArticlePubMedGoogle Scholar
  8. Socransky SS, Haffajee AD. The bacterial etiology of destructive periodontal disease: current concepts. J Periodontol. 1992;63(4 Suppl):322–31.View ArticlePubMedGoogle Scholar
  9. Eke PI, Dye BA, Wei L, Thornton-Evans GO, Genco RJ. Prevalence of periodontitis in adults in the United States: 2009 and 2010. J Dent Res. 2012;91(10):914–20.View ArticlePubMedGoogle Scholar
  10. Chambrone L, Foz AM, Guglielmetti MR, Pannuti CM, Artese HP, Feres M, Romito GA. Periodontitis and chronic kidney disease: a systematic review of the association of diseases and the effect of periodontal treatment on estimated glomerular filtration rate. J Clin Periodontol. 2013;40(5):443–56.View ArticlePubMedGoogle Scholar
  11. Xu F, Lu B. Prospective association of periodontal disease with cardiovascular and all-cause mortality: NHANES III follow-up study. Atherosclerosis. 2011;218(2):536–42.View ArticlePubMedGoogle Scholar
  12. Humphrey LL, Fu R, Buckley DI, Freeman M, Helfand M. Periodontal disease and coronary heart disease incidence: a systematic review and meta-analysis. J Gen Intern Med. 2008;23(12):2079–86.View ArticlePubMedPubMed CentralGoogle Scholar
  13. Ricardo AC, Athavale A, Chen J, Hampole H, Garside D, Marucha P, Lash JP. Periodontal disease, chronic kidney disease and mortality: results from the third National Health and nutrition examination survey. BMC Nephrol. 2015;16:97.View ArticlePubMedPubMed CentralGoogle Scholar
  14. Kshirsagar AV, Craig RG, Moss KL, Beck JD, Offenbacher S, Kotanko P, Klemmer PJ, Yoshino M, Levin NW, Yip JK, et al. Periodontal disease adversely affects the survival of patients with end-stage renal disease. Kidney Int. 2009;75(7):746–51.View ArticlePubMedGoogle Scholar
  15. Chen LP, Chiang CK, Peng YS, Hsu SP, Lin CY, Lai CF, Hung KY. Relationship between periodontal disease and mortality in patients treated with maintenance hemodialysis. Am J Kidney Dis. 2011;57(2):276–82.View ArticlePubMedGoogle Scholar
  16. Almeida S, Figueredo CM, Lemos C, Bregman R, Fischer RG. Periodontal treatment in patients with chronic kidney disease: a pilot study. J Periodontal Res. 2016.Google Scholar
  17. Grubbs V, Garcia F, Jue BL, Vittinghoff E, Ryder M, Lovett D, Carrillo J, Offenbacher S, Ganz P, Bibbins-Domingo K, et al. The kidney and periodontal disease (KAPD) study: a pilot randomized controlled trial testing the effect of non-surgical periodontal therapy on chronic kidney disease. Contemp Clin Trials. 2017;53:143–50.View ArticlePubMedGoogle Scholar
  18. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA. 2000;283(15):2008–12.View ArticlePubMedGoogle Scholar
  19. Armitage GC. The complete periodontal examination. Periodontol. 2004;34:22–33.View ArticleGoogle Scholar
  20. Croxson LJ. A simplified periodontal screening examination: the community periodontal index of treatment needs (WHO) in general practice. Int Dent J. 1984;34(1):28–34.PubMedGoogle Scholar
  21. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 Suppl 1):S1–266.Google Scholar
  22. Wells G, Shea B, O’connell D, Peterson J, Welch V, Losos M, et al. The Newcastle–Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses; 2000. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
  23. Palmer S, Ruospo M, Wong G, Craig JC, Petruzzi M, De Benedittis M, Ford P, Johnson D, Tonelli M, Natale P, et al. Periodontitis and early mortality in adults with kidney failure treated with hemodialysis: a multi national observational study. Nephrol Dial Transplant. 2015;30:iii625.View ArticleGoogle Scholar
  24. Blach A, Franek E, Witula A, Kolonko A, Chudek J, Drugacz J, Wiecek A. The influence of chronic periodontitis on serum TNF-alpha, IL-6 and hs-CRP concentrations, and function of graft and survival of kidney transplant recipients. Clin Transpl. 2009;23(2):213–9.View ArticleGoogle Scholar
  25. de Souza CM, Braosi AP, Luczyszyn SM, Olandoski M, Kotanko P, Craig RG, Trevilatto PC, Pecoits-Filho R. Association among oral health parameters, periodontitis, and its treatment and mortality in patients undergoing hemodialysis. J Periodontol. 2014;85(6):e169–78.View ArticlePubMedGoogle Scholar
  26. Ruokonen H, Nylund K, Furuholm J, Meurman JH, Sorsa T, Kotaniemi K, Ortiz F, Heikkinen AM. Oral health and mortality in patients with chronic kidney disease. J Periodontol. 2016:1–11.Google Scholar
  27. Chen YT, Shih CJ, Ou SM, Hung SC, Lin CH, Tarng DC. Periodontal disease and risks of kidney function decline and mortality in older people: a community-based cohort study. Am J Kidney Dis. 2015;66(2):223–30.View ArticlePubMedGoogle Scholar
  28. Palmer S, Ruospo M, Wong G, Craig J, Johnson DW, Ford P, Tonelli M, Petruzzi M, De Benedittis M, Strippoli G. Periodontitis and risk of all-cause and cardiovascular mortality in adults with end-stage kidney disease: a propensity-matched study. Nephrology. 2015;20:51.View ArticleGoogle Scholar
  29. Palmer S, Ruospo M, Pellgrini F, Strippoli GFM. Periodontal disease and all cause and cardiovascular mortality in hemodialysis patients: a prospective multinational cohort study. Nephrol Dial Transplant. 2013;28:i258.View ArticleGoogle Scholar
  30. Sharma P, Dietrich T, Ferro CJ, Cockwell P, Chapple IL. Association between periodontitis and mortality in stages 3-5 chronic kidney disease: NHANES III and linked mortality study. J Clin Periodontol. 2016;43(2):104–13.View ArticlePubMedPubMed CentralGoogle Scholar
  31. Garneata L, Slusanschi O, Dragomir DR, Corbu-Stancu A, Barbulescu C, Mircescu G. Impact of periodontal disease on survival of haemodialysis patients. Nephrol Dial Transplant. 2014;29:iii288.View ArticleGoogle Scholar
  32. Shultis WA, Weil EJ, Looker HC, Curtis JM, Shlossman M, Genco RJ, Knowler WC, Nelson RG. Effect of periodontitis on overt nephropathy and end-stage renal disease in type 2 diabetes. Diabetes Care. 2007;30(2):306–11.View ArticlePubMedGoogle Scholar
  33. Genctoy G, Ozbek M, Avcu N, Kahraman S, Kirkpantur A, Yilmaz R, Kansu O, Arici M, Altun B, Erdem Y, et al. Gingival health status in renal transplant recipients: relationship between systemic inflammation and atherosclerosis. Int J Clin Pract. 2007;61(4):577–82.View ArticlePubMedGoogle Scholar
  34. Cengiz MI, Bal S, Gokcay S, Cengiz K. Does periodontal disease reflect atherosclerosis in continuous ambulatory peritoneal dialysis patients? J Periodontol. 2007;78(10):1926–34.View ArticlePubMedGoogle Scholar
  35. Zhang L, Sang X, Zakir R, Li S, Abula D, Li J, Wang S, Liu J. Association of all-cause mortality in chronic kidney disease stage 3-5 patients with periodontitis in uygur people in Xinjiang: a 6-year longitudinal, observational study. Hong Kong J Nephrol. 2015;17(2):S113.View ArticleGoogle Scholar
  36. Madore F. Periodontal disease: a modifiable risk factor for cardiovascular disease in ESRD patients? Kidney Int. 2009;75(7):672–4.View ArticlePubMedGoogle Scholar
  37. Castillo A, Mesa F, Liebana J, Garcia-Martinez O, Ruiz S, Garcia-Valdecasas J, O'Valle F. Periodontal and oral microbiological status of an adult population undergoing haemodialysis: a cross-sectional study. Oral Dis. 2007;13(2):198–205.View ArticlePubMedGoogle Scholar
  38. Franek E, Blaschyk R, Kolonko A, Mazur-Psonka L, Langowska-Adamczyk H, Kokot F, Wiecek A. Chronic periodontitis in hemodialysis patients with chronic kidney disease is associated with elevated serum C-reactive protein concentration and greater intima-media thickness of the carotid artery. J Nephrol. 2006;19(3):346–51.PubMedGoogle Scholar
  39. Thorman R, Neovius M, Hylander B. Prevalence and early detection of oral fungal infection: a cross-sectional controlled study in a group of Swedish end-stage renal disease patients. Scand J Urol Nephrol. 2009;43(4):325–30.View ArticlePubMedGoogle Scholar
  40. Chuang SF, Sung JM, Kuo SC, Huang JJ, Lee SY. Oral and dental manifestations in diabetic and nondiabetic uremic patients receiving hemodialysis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;99(6):689–95.View ArticlePubMedGoogle Scholar
  41. Siribamrungwong M, Puangpanngam K. Treatment of periodontal diseases reduces chronic systemic inflammation in maintenance hemodialysis patients. Ren Fail. 2012;34(2):171–5.View ArticlePubMedGoogle Scholar
  42. Choi HM, Han K, Park YG, Park JB. Associations between the number of natural teeth and renal dysfunction. Medicine (Baltimore). 2016;95(34):e4681.View ArticleGoogle Scholar
  43. Palmer SC, Ruospo M, Wong G, Craig JC, Petruzzi M, De Benedittis M, Ford P, Johnson DW, Tonelli M, Natale P, et al. Dental health and mortality in people with end-stage kidney disease treated with Hemodialysis: a multinational cohort study. Am J Kidney Dis. 2015;66(4):666–76.View ArticlePubMedGoogle Scholar
  44. Ruospo M, Palmer SC, Craig JC, Gentile G, Johnson DW, Ford PJ, Tonelli M, Petruzzi M, De Benedittis M, Strippoli GF. Prevalence and severity of oral disease in adults with chronic kidney disease: a systematic review of observational studies. Nephrol Dial Transplant. 2014;29(2):364–75.View ArticlePubMedGoogle Scholar
  45. Tanner NT, Kanodra NM, Gebregziabher M, Payne E, Halbert CH, Warren GW, Egede LE, Silvestri GA. The association between smoking abstinence and mortality in the National Lung Screening Trial. Am J Respir Crit Care Med. 2016;193(5):534–41.View ArticlePubMedGoogle Scholar
  46. Wulaningsih W, Serrano FE, Utarini A, Matsuguchi T, Watkins J. Smoking, second-hand smoke exposure and smoking cessation in relation to leukocyte telomere length and mortality. Oncotarget. 2016;Google Scholar
  47. Yoshihara A, Iwasaki M, Miyazaki H, Nakamura K. Bidirectional relationship between renal function and periodontal disease in older Japanese women. J Clin Periodontol. 2016;43(9):720–6.View ArticlePubMedGoogle Scholar
  48. Grubbs V, Vittinghoff E, Taylor G, Kritz-Silverstein D, Powe N, Bibbins-Domingo K, Ishani A, Cummings SR. The association of periodontal disease with kidney function decline: a longitudinal retrospective analysis of the MrOS dental study. Nephrol Dial Transplant. 2016;31(3):466–72.View ArticlePubMedGoogle Scholar
  49. Wahid A, Chaudhry S, Ehsan A, Butt S, Ali Khan A. Bidirectional relationship between Chronic Kidney Disease & Periodontal Disease. Pakistan J Med Sci. 2013;29(1):211–5.Google Scholar
  50. Fisher MA, Taylor GW, West BT, McCarthy ET. Bidirectional relationship between chronic kidney and periodontal disease: a study using structural equation modeling. Kidney Int. 2011;79(3):347–55.View ArticlePubMedGoogle Scholar
  51. Kshirsagar AV, Craig RG, Beck JD, Moss K, Offenbacher S, Kotanko P, Yoshino M, Levin NW, Yip JK, Almas K, et al. Severe periodontitis is associated with low serum albumin among patients on maintenance hemodialysis therapy. Clin J Am Soc Nephrol. 2007;2(2):239–44.View ArticlePubMedGoogle Scholar
  52. Beck JD, Slade G, Offenbacher S. Oral disease, cardiovascular disease and systemic inflammation. Periodontol. 2000;23:110–20.View ArticleGoogle Scholar
  53. Cairo F, Gaeta C, Dorigo W, Oggioni MR, Pratesi C, Pini Prato GP, Pozzi G. Periodontal pathogens in atheromatous plaques. A controlled clinical and laboratory trial. J Periodontal Res. 2004;399(6):442–6.View ArticleGoogle Scholar
  54. Seinost G, Wimmer G, Skerget M, Thaller E, Brodmann M, Gasser R, Bratschko RO, Pilger E. Periodontal treatment improves endothelial dysfunction in patients with severe periodontitis. Am Heart J. 2005;149(6):1050–4.View ArticlePubMedGoogle Scholar
  55. Wehmeyer MM, Kshirsagar AV, Barros SP, Beck JD, Moss KL, Preisser JS, Offenbacher S. A randomized controlled trial of intensive periodontal therapy on metabolic and inflammatory markers in patients with ESRD: results of an exploratory study. Am J Kidney Dis. 2013;61(3):450–8.View ArticlePubMedGoogle Scholar
  56. Fouque D, Kalantar-Zadeh K, Kopple J, Cano N, Chauveau P, Cuppari L, Franch H, Guarnieri G, Ikizler TA, Kaysen G, et al. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int. 2008;73(4):391–8.View ArticlePubMedGoogle Scholar
  57. Piccoli GB, Deagostini MC, Vigotti FN, Ferraresi M, Moro I, Consiglio V, Scognamiglio S, Mongilardi E, Clari R, Aroasio E, et al. Which low-protein diet for which CKD patient? An observational, personalized approach. Nutrition. 2014;30(9):992–9.View ArticlePubMedGoogle Scholar
  58. Chen LP, Chiang CK, Chan CP, Hung KY, Huang CS. Does periodontitis reflect inflammation and malnutrition status in hemodialysis patients? Am J Kidney Dis. 2006;47(5):815–22.View ArticlePubMedGoogle Scholar
  59. Garneata L, Slusanschi O, Preoteasa E, Corbu-Stancu A, Mircescu G. Periodontal status, inflammation, and malnutrition in hemodialysis patients - is there a link? J Ren Nutr. 2015;25(1):67–74.View ArticlePubMedGoogle Scholar
  60. Maisonneuve P, Amar S, Lowenfels AB. Periodontal disease, edentulism, and pancreatic cancer: a meta-analysis. Ann Oncol. 2017;28(5):985–95.PubMedGoogle Scholar
  61. Ye L, Jiang Y, Liu W, Tao H. Correlation between periodontal disease and oral cancer risk: a meta-analysis. J Cancer Res Ther. 2016;12(Supplement):C237–c240.View ArticlePubMedGoogle Scholar
  62. Abariga SA, Whitcomb BW. Periodontitis and gestational diabetes mellitus: a systematic review and meta-analysis of observational studies. BMC Pregnancy Childbirth. 2016;16(1):344.View ArticlePubMedPubMed CentralGoogle Scholar
  63. Zeng XT, Tu ML, Liu DY, Zheng D, Zhang J, Leng W. Periodontal disease and risk of chronic obstructive pulmonary disease: a meta-analysis of observational studies. PLoS One. 2012;7(10):e46508.View ArticlePubMedPubMed CentralGoogle Scholar
  64. Fernandez-Plata R, Olmedo-Torres D, Martinez-Briseno D, Garcia-Sancho C, Franco-Marina F, Gonzalez-Cruz H. Prevalence of severe periodontal disease and its association with respiratory disease in hospitalized adult patients in a tertiary care center. Gaceta medica de Mexico. 2015;151(5):608–13.PubMedGoogle Scholar

Copyright

© The Author(s). 2017

Advertisement